Using an extended investigation approach (Figure 1) we show that CpG sites in different regions of NKX6-2 present hypermethylation, in both metastasized primary RCC tissue and RCC-derived distant metastatic tissues. The gene discussed is NKX6-2; the disease is renal cell carcinoma.